Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-03 Sale | 2024-10-03 9:55 pm | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 6,272 | $0.55 | $3,450 | 19,011 (Direct) | View |
| 2024-09-16 Sale | 2024-09-17 7:18 pm | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 215 | $0.6908 | $149 | 11,533 (Direct) | View |
| 2024-06-17 Sale | 2024-06-18 9:26 pm | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 244 | $1.2627 | $308 | 11,748 (Direct) | View |
| 2024-04-04 Sale | 2024-04-08 7:31 pm | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | 1,008 | $2.6351 | $2,656 | 11,992 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-03 Option Award | 2026-02-05 5:00 pm | N/A N/A | Definium Therapeutics Inc. | DFTX | Wiley Matthew T. Chief Commercial Officer | 115,000 | $0 | 115,000 (Direct) | View |
| 2024-07-22 Option Award | 2025-04-01 6:06 pm | N/A 2034-07-22 | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. See Remarks | 1,875 | $0 | 1,875 (Direct) | View |
| 2025-03-17 Option Award | 2025-03-18 4:45 pm | N/A 2035-03-16 | Mind Medicine (MindMed) Inc. | MNMD | Wiley Matthew T. Chief Commercial Officer | 350,000 | $0 | 350,000 (Direct) | View |
| 2024-09-17 Option Award | 2024-10-03 9:55 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 21,250 | $0 | 19,011 (Direct) | View |
| 2024-09-15 Exercise | 2024-09-17 7:18 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 750 | $0 | 11,533 (Direct) | View |
| 2024-06-15 Exercise(A) | 2024-09-17 7:17 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 750 | $0 | 8,250 (Direct) | View |
| 2024-06-15 Exercise | 2024-06-18 9:26 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 750 | $0 | 11,748 (Direct) | View |
| 2024-03-15 Exercise | 2024-04-08 7:31 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | 3,000 | $0 | 11,992 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-16 5:58 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | 48,000 | $0 | 48,000 (Direct) | View |
| 2022-01-17 Option Award | 2022-01-19 4:19 pm | N/A 2032-01-16 | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | 85,000 | $0 | 85,000 (Direct) | View |
| 2021-06-30 Tax Withholding | 2021-07-02 4:36 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Wiley Matthew T. Chief Commercial Officer | 5,151 | $3.51 | 109,246 (Direct) | View |